Crinetics Pharmaceuticals (CRNX) Treasury Shares (2017 - 2025)

Crinetics Pharmaceuticals' (CRNX) quarterly Treasury Shares came in at $112000.0 in Q2 2025.

Crinetics Pharmaceuticals (CRNX) Treasury Shares (2017 - 2025) Analysis & Trends

Crinetics Pharmaceuticals' Treasury Shares history runs 1 years deep, the most recent figure standing at $112000.0 for Q2 2025.

On a quarterly basis, Treasury Shares changed N/A year-over-year to $48.4 million in Q2 2018; TTM through Jun 2018 was $48.4 million, a N/A change from a year earlier, with the FY2017 full-year figure at $28.8 million, up 66.67% from the prior year.
Treasury Shares held at $48.4 million in Q2 2018 per CRNX's latest filing, from $48.4 million in the prior quarter.
Across five years, Treasury Shares topped out at $48.4 million in Q2 2018 and bottomed at $28.8 million in Q4 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Oculis Holding AG	66,681.27 Bn	66,680.98 Bn	-	-21,709.08
2	Nanobiotix	1,946.26 Bn	1,946.20 Bn	-	265,401.92
3	Akari Therapeutics	1,132.35 Bn	1,132.35 Bn	-	-
4	BeOne Medicines	473.25 Bn	468.46 Bn	1.35 Bn	-
5	Vertex Pharmaceuticals	123.17 Bn	115.92 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	69.54 Bn	60.79 Bn	3.31 Bn	19.41 Bn
7	Belite Bio	63.20 Bn	63.20 Bn	-	-
8	Argenx Se	56.91 Bn	51.72 Bn	1.41 Bn	-
9	Revolution Medicines	38.23 Bn	38.23 Bn	-	5.14 Mn
10	Crinetics Pharmaceuticals	8.71 Bn	7.42 Bn	10.53 Mn	-

Download Data